Archive


Category: BioMed X

  • Big pharma companies partner to form AI-based start-up

    Israel-based AION Labs and German independent research institute BioMed X announced its third global call for applications to form a new start-up company focused on using AI to design and optimise antibodies for targeted therapies.  Noga Yerushalmi, investment director at M Ventures (the venture arm of Merck), tells us how AION Labs was formed and […]